Currently out of the existing stock ratings of Brian Cheng, 33 are a BUY (75%), 10 are a HOLD (22.73%), 1 are a SELL (2.27%).

Brian Cheng

Work Performance Price Targets & Ratings Chart

Analyst Brian Cheng, employed carries an average stock price target met ratio of 34.52% that have a potential upside of 21.35% achieved within 60 days on average. Previously, Brian Cheng worked at JPMORGAN.

Brian Cheng’s has documented 87 price targets and ratings displayed on 16 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on PTGX, Protagonist Therapeutics at 28-Feb-2024.

Wall Street Analyst Brian Cheng

Analyst best performing recommendations are on APLS (APELLIS PHARMACEUTICALS).
The best stock recommendation documented was for APLS (APELLIS PHARMACEUTICALS) at 10/12/2023. The price target of $46 was fulfilled within 1 day with a profit of $2.1 (4.78%) receiving and performance score of 47.84.

Average potential price target upside

ARCT Arcturus Therapeutics Holdings PSTX Poseida Therapeutics ADCT ADC Therapeutics SA IMNM Immunome  SRRA Sierra Oncology GOSS Gossamer Bio APLS Apellis Pharmaceuticals NTLA Intellia Therapeutics ROIV Roivant Sciences Ltd XNCR Xencor ACET Adicet Bio BCAB Bioatla  ALLO Allogene Therapeutics MRSN Mersana Therapeutics PTGX Protagonist Therapeutics ZYME Zymeworks . Common Stock

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

86

$60.04 (231.28%)

87

1 months 9 days ago

1/3 (33.33%)

$58.74 (215.48%)

75

Buy

48

$22.04 (84.90%)

40

4 months 11 days ago

4/8 (50%)

$10.09 (26.62%)

195

Buy

51

$25.04 (96.46%)

51

6 months 22 days ago

14/24 (58.33%)

$25.48 (99.84%)

165

Buy

54

$28.04 (108.01%)

54

9 months 28 days ago

3/5 (60%)

$21.39 (65.59%)

559

Buy

36

11 months 5 days ago

2/2 (100%)

$15.83 (78.48%)

271

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Brian Cheng is most bullish on?

Potential upside of $5.77 has been obtained for ALLO (ALLOGENE THERAPEUTICS)

Which stock is Brian Cheng is most reserved on?

Potential downside of $4.41 has been obtained for PTGX (PROTAGONIST THERAPEUTICS)

What Year was the first public recommendation made by Brian Cheng?

On 2019

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?